Avandia should be off the market, Public Citizen told the FDA last week, citing the life-threatening risks of the drug, including heart and liver damage.
It was the second blow to Avandia in the last two weeks for Avandia. The American Diabetes Association and a European counterpart jointly released updated treatment guidelines for doctors that recommended against using Avandia.
Dr. John B. Buse, chief of endocrinology at the University of North Carolina in Chapel Hill, and president of the American Diabetes Association has expressed grave concerns about Avandia, citing “a worrisome trend in cardiovascular deaths and severe adverse events” among patients using the Avandia. Dr. Buse’s letter was also critical of the Glaxo’s marketing of Avandia, accusing the company of “pervasive and systemic” efforts to understate the Avandia’s risks and overstate its benefits.
Some lawyers believe an Avandia settlement is in the near future. If you have a potential claim and want to learn more about the legal proceedings pending, call us at 800-553-8082.